Related Experiment Videos
[Cyto-reduction of rectal cancer after preoperative chemoradiotherapy]
W Sánchez Maldonado1, D Rodríguez Coria, P Luna Pérez
1Departamento de Cirugía Colorrectal, Centro Médico Nacional S. XXI I.M.S.S. México, D.F.
Revista De Gastroenterologia De Mexico
|July 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Rapunzel's syndrome (trichobezoar)].
Revista de gastroenterologia de Mexico·1998
[Hereditary nonpolyposis colorectal cancer. Lynch syndrome].
Revista de gastroenterologia de Mexico·1995
[Severe bowel complications in SARS-CoV-2 patients receiving protocolized care].
Revista de gastroenterologia de Mexico·2024
[Liver injury due to COVID-19 in critically ill adult patients. A retrospective study].
Revista de gastroenterologia de Mexico·2023
[Impact on the incidence of gastrointestinal perforation during the COVID-19 pandemic in the Costa del Sol healthcare system area].
Revista de gastroenterologia de Mexico·2022
[Two consecutive attacks of diarrhea in 15 COVID-19 patients: An antibiotic-associated one following the viral one].
Revista de gastroenterologia de Mexico·2021
[Position statement of the Latin American Dysphagia Society for the management of oropharyngeal and esophageal dysphagia during the COVID-19 pandemic].
Revista de gastroenterologia de Mexico·2021
Venetoclax-based Therapy Improves Outcomes across the Evolving Biology of t(11;14) Multiple Myeloma.
medRxiv : the preprint server for health sciences·2026
Mitochondrial rewiring supports survival of triple negative breast cancer cells after ionizing radiation.
bioRxiv : the preprint server for biology·2026
A mammary-specific microfluidic device for studying post-radiotherapy vascular-immune cell interactions.
bioRxiv : the preprint server for biology·2026
Impact of Trastuzumab and Pertuzumab on HER2 Localization and the Estrogen Receptor Cistrome in ER+/HER2+ Breast Cancer.
bioRxiv : the preprint server for biology·2026
Immune Profiling after treatment with an Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Treatment-Refractory Progressive Multiple Sclerosis.
medRxiv : the preprint server for health sciences·2026